Prognostic impact of HER2 overexpression/amplification in women with pT1a N0 M0 breast cancer with known screening status: First results from a multicenter population-based cancer registry study.

被引：0
|
作者：
Musolino, Antonino
Michiara, Maria
Boggiani, Daniela
Sikokis, Angelica
Rimanti, Anita
Pellegrino, Benedetta
Martella, Eugenia
Bozzani, Francesco
Sgargi, Paolo
Panebianco, Michele
Bisagni, Giancarlo
Falcini, Fabio
Pinto, Carmine
机构：
[1] Univ Hosp Parma, Med Oncol Unit, Parma, Italy
[2] Univ Hosp Parma, Canc Registry Parma Prov, Parma, Italy
[3] Univ Hosp Parma, Sect Anat & Pathol, Parma, Italy
[4] Azienda Osped Arcispedale S Maria Nuova, IRCCS, Med Oncol Unit, Reggio Emilia, Italy
[5] IRCCS, Romagna Tumor Registry, Ist Sci Romagnolo Studio & Cura Tumori, Meldola, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.594
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
594
引用
收藏
页数：1
相关论文
共 34 条
  • [1] Prognostic impact of HER2 overexpression/amplification in women with pT1a NO MO breast cancer with known screening status: Results from a multicenter population-based cancer registry study
    Musolino, A.
    Michiara, M.
    Boggiani, D.
    Sikokis, A.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Sgargi, P.
    Falcini, F.
    Pinto, C.
    CANCER RESEARCH, 2016, 76
  • [2] HER2/NEU OVEREXPRESSION IN pT1a OR pT1b, N0, M0 BREAST CANCER
    Petroni, S.
    Asselti, M.
    Giotta, F.
    Quero, C.
    D'Amico, C.
    Marzano, A. L.
    Daprile, R.
    Salvatore, C.
    Colucci, G.
    Simone, G.
    CANCER TREATMENT REVIEWS, 2010, 36 : S103 - S103
  • [3] Prognostic impact of interval breast cancer detection in women with pT1a N0M0 breast cancer with HER2-positive status: Results from a multicentre population-based cancer registry study
    Musolino, A.
    Falcini, F.
    Sikokis, A.
    Boggiani, D.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Zamagni, C.
    Esposti, R. Degli
    Cortesi, L.
    Bisagni, G.
    Cavanna, L.
    Frassoldati, A.
    Sgargi, P.
    Michiara, M.
    EUROPEAN JOURNAL OF CANCER, 2018, 88 : 10 - 20
  • [4] Prognostic Impact of Interval Breast Cancer Detection in Women with pT1aN0M0 Breast Cancer with HER2-positive Status: Results from a Multicenter Population-based Cancer Registry Study
    Boggiani, D.
    Sikokis, A.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Cortesi, L.
    Panebianco, M.
    Porzio, R.
    Frassoldati, A.
    Sgargi, P.
    Falcini, F.
    Michiara, M.
    Musolino, A.
    ANNALS OF ONCOLOGY, 2016, 27
  • [5] Prognostic impact of interval breast cancer detection in women with pT1aN0M0 breast cancer with HER2-positive status: results from a multicenter population-based cancer registry study
    Musolino, A.
    Sikokis, A.
    Boggiani, D.
    Rimanti, A.
    Pellegrino, B.
    Silini, E. M.
    Campanini, N.
    Barbieri, E.
    Cortesi, L.
    Panebianco, M.
    Porzio, R.
    Frassoldati, A.
    Sgargi, P.
    Falcini, F.
    Michiara, M.
    ANNALS OF ONCOLOGY, 2016, 27
  • [6] \HER-2/neu Overexpression as Prognostic Factor in Small Size Breast Cancer (pT1, N0, M0)
    Petroni, S.
    Giotta, F.
    Asselti, M.
    Quero, C.
    Marzano, A. L.
    Giannone, G.
    Rubini, V.
    Simone, G.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S134 - S134
  • [7] Prognostic Significance of the Number of Negative Axillary Lymph Nodes in Patients with pT1-2 N0 M0 Breast Cancer: A Population-Based Study
    Martinez-Ramos, David
    Escrig-Sos, Javier
    Torrella-Ramos, Ana
    Alcalde-Sanchez, Miguel
    Salvador-Sanchis, Jose Luis
    Ferraris, Cristina
    Greco, Marco
    BREAST JOURNAL, 2010, 16 (04): : 437 - 439
  • [8] HER2 Overexpression Is a Major Risk Factor for Recurrence in pT1a-b, N0 Breast Cancer: A French Regional Population-Based Study of 671 Patients
    Bibeau, F.
    Boissiere-Michot, F.
    Denouel, A.
    Szablewski, V.
    Perrocchia, H.
    Pignodel, C.
    de Vullerin, A. Gudin
    Leaha, C.
    Chateau, M-C
    Barneon, G.
    Vic, P.
    Garnier, A.
    Granier, M.
    Roger, P.
    MODERN PATHOLOGY, 2012, 25 : 26A - 26A
  • [9] Prognostic role of HER2 expression in patients with ER-positive/HER2-negative breast cancer: Results from a population-based cancer registry study.
    Musolino, Antonino
    Serra, Olga
    Pellegrino, Benedetta
    Tommasi, Chiara
    Zanoni, Daniele
    Cortesi, Laura
    Canino, Fabio
    Piacentini, Federico
    Sgargi, Paolo
    Michiara, Maria
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Radiation and survival in women over 70 with T1 N0 M0 ER-negative breast cancer from 1990 to 2007: A population-based analysis
    Wojcieszynski, A. P.
    Shen, X.
    Mishra, M. V.
    Anne, P. R.
    Showalter, T. N.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
1234